W

Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871

Watchlist Manager
Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
Watchlist
Price: 11.71 CNY -0.26%
Market Cap: 1.9B CNY
Have any thoughts about
Wuhan Hvsen Biotechnology Co Ltd?
Write Note

Wuhan Hvsen Biotechnology Co Ltd
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Wuhan Hvsen Biotechnology Co Ltd
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
W
Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
Cash Taxes Paid
-ÂĄ41.2m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash Taxes Paid
ÂĄ589.6m
CAGR 3-Years
0%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash Taxes Paid
-ÂĄ1.1B
CAGR 3-Years
-11%
CAGR 5-Years
-14%
CAGR 10-Years
-18%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash Taxes Paid
-ÂĄ2.2B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
-5%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash Taxes Paid
-ÂĄ2.4B
CAGR 3-Years
2%
CAGR 5-Years
-6%
CAGR 10-Years
-5%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash Taxes Paid
-ÂĄ49m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Wuhan Hvsen Biotechnology Co Ltd
Glance View

Market Cap
1.9B CNY
Industry
Pharmaceuticals

HVSEN Biotechnology Co., Ltd. engages in the research and development, production, and sale of veterinary drugs. The company is headquartered in Wuhan, Hubei and currently employs 828 full-time employees. The company went IPO on 2020-08-24. The Company’s main products include veterinary active pharmaceutical ingredients, veterinary chemical preparations, veterinary traditional Chinese medicine preparations, feed and additives and environmental improvers, such as tyvanicin tartrate, florfenicol powder, banqing granules and piglet composites pre-mixed feed, etc. The firm mainly conducts its businesses in the China market.

Intrinsic Value
22.35 CNY
Undervaluation 48%
Intrinsic Value
Price
W

See Also

What is Wuhan Hvsen Biotechnology Co Ltd's Cash Taxes Paid?
Cash Taxes Paid
-41.2m CNY

Based on the financial report for Dec 31, 2023, Wuhan Hvsen Biotechnology Co Ltd's Cash Taxes Paid amounts to -41.2m CNY.

What is Wuhan Hvsen Biotechnology Co Ltd's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 5Y
-1%

Over the last year, the Cash Taxes Paid growth was -46 114%.

Back to Top